Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

13.68 +0.60 (+4.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,039,145
Open 13.11
Bid (Size) 13.70 (3)
Ask (Size) 13.85 (4)
Prev. Close 13.08
Today's Range 12.81 - 13.71
52wk Range 6.780 - 24.76
Shares Outstanding 109,588,527
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending... 
Via StockStory
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. 
Via StockStory
Topics Stocks World Trade

Performance

YTD
-3.6%
-3.6%
1 Month
+14.8%
+14.8%
3 Month
+58.9%
+58.9%
6 Month
-5.3%
-5.3%
1 Year
-25.4%
-25.4%

More News

Read More
3 Unprofitable Stocks We’re Skeptical Of
Via StockStory
What's Driving the Market Sentiment Around 10x Genomics?
Via Benzinga
Forecasting The Future: 7 Analyst Projections For 10x Genomics
Via Benzinga
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know
Via StockStory
Topics Lawsuit World Trade
3 Russell 2000 Stocks with Red Flags
Via StockStory
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know
Via StockStory
Topics ETFs Stocks World Trade
Demystifying 10x Genomics: Insights From 8 Analyst Reviews
Via Benzinga
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)
Via StockStory
Topics Artificial Intelligence
Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy Government Stocks
1 Cash-Producing Stock with Exciting Potential and 2 to Ignore
Via StockStory
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Be Wary Of
Via StockStory
Topics Artificial Intelligence
TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions
Via StockStory
Topics Intellectual Property
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration
Via Benzinga
Topics Government
Powell, Mayville Engineering, Graham Corporation, Hyster-Yale Materials Handling, and 10x Genomics Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
Via Benzinga
Topics Artificial Intelligence
Why 10x Genomics Stock Was Sliding This Week
Via The Motley Fool
Topics Intellectual Property
1 Small-Cap Stock with Exciting Potential and 2 to Turn Down
Via StockStory
3 Volatile Stocks Walking a Fine Line
Via StockStory
Analyst Expectations For 10x Genomics's Future
Via Benzinga
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
Via Benzinga
Topics Artificial Intelligence
3 Stocks Under $10 Walking a Fine Line
Via StockStory
10x Genomics CEO Calls NIH The 'Foundational Jewel' Of Biomedical Progress, Says 40% To 50% Of Revenue Supported By Academic And Government Research Funding — Pulls Full Year Revenue Guidance
Via Benzinga
10x Genomics’s (NASDAQ:TXG) Q1: Strong Sales But Quarterly Revenue Guidance Significantly Misses Expectations
Via StockStory

Frequently Asked Questions

Is 10x Genomics, Inc. - Common Stock publicly traded?
Yes, 10x Genomics, Inc. - Common Stock is publicly traded.
What exchange does 10x Genomics, Inc. - Common Stock trade on?
10x Genomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 10x Genomics, Inc. - Common Stock?
The ticker symbol for 10x Genomics, Inc. - Common Stock is TXG on the Nasdaq Stock Market
What is the current price of 10x Genomics, Inc. - Common Stock?
The current price of 10x Genomics, Inc. - Common Stock is 13.68
When was 10x Genomics, Inc. - Common Stock last traded?
The last trade of 10x Genomics, Inc. - Common Stock was at 08/04/25 04:00 PM ET
What is the market capitalization of 10x Genomics, Inc. - Common Stock?
The market capitalization of 10x Genomics, Inc. - Common Stock is 1.50B
How many shares of 10x Genomics, Inc. - Common Stock are outstanding?
10x Genomics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.